Involvement of Speciôc Transport System of Renal Basolateral Membranes in Distribution of Nicotine in Rats

Drug Metabolism and Pharmacokinetics

Volumn 17, Issue 6, 2002, Pages 554-560

  Fukada, Atsuko ^a   Saito, Hideyuki ^a   Urakami, Yumiko ^a   Okuda, Masahiro ^a   Inui, Ken ichi ^a  

^a KYOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

kidney; nicotine; renal cortical slice; tissue distribution

Indexed keywords

EID: 84973337409     PISSN: 13474367     EISSN: 18800920     Source Type: Journal    
DOI: 10.2133/dmpk.17.554     Document Type: Article

References (32)

1. Miller, R. P., Rotenberg, K. S. and Adir, J.: Effect of dose on the pharmacokinetics of intravenous nicotine in the rat. Drug Metab. Dispos., 5: 436-443 (1977).
2. Schievelbein, H.: Nicotine, resorption and fate. Pharmac. Ther., 18: 233-248 (1982).
3. Hwa Jung, B., Chul Chung, B., Chung, S. J. and Shim, C. K.: Diŝerent pharmacokinetics of nicotine following intravenous administration of nicotine base and nicotine hydrogen tartarate in rats. J. Control Release, 77: 183-190 (2001).
4. Svensson, C. K.: Clinical pharmacokinetics of nicotine. Clin. Pharmacokin., 12: 30-40 (1987).
5. Russell, M. A. and Feyerabend, C.: Cigarette smoking: a dependence on high-nicotine boli. Drug Metab. Rev., 8: 29-57 (1978).
6. Kyerematen, G. A. and Vesell, E. S.: Metabolism of nicotine. Drug Metab. Rev., 23: 3-41 (1991).
7. Plowchalk, D. R., Andersen, M. E. and Debethizy, J. D.: A physiologically based pharmacokinetics model for nicotine disposition in the Spague-Dawley rat. Toxicol. Appl. Pharmacol., 116: 177-188 (1992).
8. Benowitz, N. L. and Jacob III, P.: Smoking and nicotine: A neurobiological approarch. In Martin, W. R., VanLoon, G. R., Imamoto, E. T. and Davis, R. (ed): Tobacco, Plenum, New York, 1987, pp. 357.
9. Lemberger, L. and Rubin, A.: Physiologic disposition of drugs of abuse. Spectrum, New York, 1978, pp. 205.
10. Tsujimoto, A., Nakashima, T., Tanino, S., Dohi, T. and Kurogochi, Y.: Tissue distribution of [3H]nicotine in dogs and rhesus monkeys. Toxicol. Appl. Pharmacol., 32: 21-31 (1975).
11. Oldendorf, W. H.: Lipid solubility and drug penetration of the blood brain barrier. Proc. Soc. Exp. Biol. Med., 147: 813-816 (1974).
12. Benowitz, N. L. and Jacob III, P.: Nicotine renal excretion rate influences nicotine intake during cigarette smoking. J. Pharmacol. Exp. Ther., 234: 153-155 (1985).
13. Rosenberg, J., Benowitz, N. L., Jacob, P. and Wilson, K. M.: Disposition kinetics and effects of intravenous nicotine. Clin. Pharmacol. Ther., 28: 517-522 (1980).
14. Inui, K., Masuda, S. and Saito, H.: Cellular and molecular aspects of drug transport in the kidney. Kidney Int., 58: 944-958 (2000).
15. Takami, K., Saito, H., Okuda, M., Takano, M. and Inui, K.: Distinct characteristics of transcellular transport between nicotine and tetraethylammonium in LLCPK1 cells. J. Pharmacol. Exp. Ther., 286: 676-680 (1998).
16. Bendayan, R., Lo, B. and Silverman, M.: Characterization of cimetidine transport in LLC-PK1 cells. J. Am. Soc. Nephrol., 5: 75-84 (1994).
17. Inui, K., Saito, H. and Hori, R.: H+-gradient-dependent active transport of tetraethylammonium cation in apicalmembrane vesicles isolated from kidney epithelial cell line LLC-PK1. Biochem. J., 227: 199-203 (1985).
18. McKinney, T. D., Scheller, M. B., Hosford, M., Lesniak, M. E. and Haseley, T. S.: Basolateral transport of tetraethylammonium by a clone of LLC-PK1 cells. J. Am. Soc. Nephrol., 2: 1507-1515 (1992).
19. Ohtomo, T., Saito, H., Inotsume, N., Yasuhara, M. and Inui, K.: Transport of levofloxacin in a kidney epithelial cell line, LLC-PK1: Interaction with organic cation transporters in apical and basolateral membranes. J. Pharmacol. Exp. Ther., 276, 1143-1148 (1996).
20. Saito, H., Yamamoto, M., Inui, K. and Hori, R.: Transcellular transport of organic cation across monolayers of kidney epithelial cell line, LLC-PK1. Am. J. Physiol., 262: C59-C66 (1992).
21. Bendayan, R., Sellers, E. M. and Silverman, M.: Inhibition kinetics of cationic drugs on N1-methylnicotinamide uptake by brush border membrane vesicles from the dog kidney cortex. Can. J. Physiol. Pharmacol., 68: 467-475 (1990).
22. Ullrich, K. J., Rumrich, G., David, C. and Fritzsch, G.: Bisubstrates: substances that interact with renal contraluminal organic anion and organic cation transport systems. Pfluägers. Arch., 425: 280-299 (1993).
23. Wong, L. T. Y., Smyth, D.D. and Sitar, D. S.: Interference with renal organic cation transport by (̎)- and (+)-nicotine at concentrations documented in plasma of habitual tobacco smokers. J. Pharmacol. Exp. Ther., 261: 21-25 (1991).
24. Bendayan, R., Sullivan, J. T., Shaw, C., Frecker, R. C. and Sellers, E. M.: Eŝect of cimetidine and ranitidine on the hepatic and renal elimination of nicotine in humans. Eur. J. Clin. Pharmacol., 38: 165-169 (1990).
25. Ito, T., Yano, I., Masuda, S., Hashimoto, Y. and Inui, K.: Distribution characteristics of levofloxacin and grepafloxacin in rat kidney. Pharm. Res., 16: 534-539 (1999).
26. Horstmann, M.: Simple high-performance liquid chromatographic method for rapid determination of nicotine and cotinine in urine. J. Chromatogr., 344: 391-396 (1985).
27. Kemmeren, J. M., Poppel, G., Verhoef, P. and Jarvis, M. J.: Plasma cotinine: stability in smokers and validation of self-reported smoke exposure in nonsmokers. Environ. Res., 66: 235-243 (1994).
28. Russell, M. A., Jarvis, M., Iyer, R. and Feyerabend, C.: Relation of nicotine yield of cigarettes to blood nicotine concentrations in smokers. Br. Med. J., 280: 972-976 (1980).
29. Benowitz, N. L.: Cotinine as a biomarker of environmental tobacco smoke exposure. Epidemiol. Rev., 18: 188-204 (1996).
30. Hori, R., Ishikawa, Y., Takano, M., Okano, T., Kitazawa, S. and Inui, K.: The interaction of cephalosporin antibiotics with renal cortex of rats: accumulation to cortical slices and binding to purîed plasma membranes. Biochem. Pharmacol., 31: 2267- 2272 (1982).
31. Urakami, Y., Okuda, M., Masuda, S., Saito, H. and Inui, K.: Functional characteristics and membrane localization of rat multispecific organic cation transporters, OCT1 and OCT2, mediating tubular secretion of cationic drugs. J. Pharmacol. Exp. Ther., 287: 800-805 (1998).
32. Urakami, Y., Okuda, M., Masuda, S., Akazawa, M., Saito, H. and Inui, K.: Distinct characteristics of organic cation transporters, OCT1 and OCT2, in the basolateral membrane of renal tubules. Pharm. Res., 18: 1528-1534 (2001).